Vijoice - NDC Database

4 records found

Page:1

0078-1021 Apr 05, 2022
Vijoice 50 mg Oral Tablet by Novartis Pharmaceuticals Corporation

0078-1028 Apr 05, 2022
Vijoice 125 mg Oral Tablet by Novartis Pharmaceuticals Corporation

0078-1035 Apr 05, 2022
VijoiceVijoice Kit by Novartis Pharmaceuticals Corporation

0078-1175 Apr 24, 2024
Vijoice 50 mg Oral Granule by Novartis Pharmaceuticals Corporation

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.